March 10 (Reuters) - Frequency Therapeutics Inc
FREQ.O :
* FREQUENCY THERAPEUTICS PROVIDES BUSINESS UPDATES AND
FOURTH
QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
* FREQUENCY THERAPEUTICS - AS OF DEC 31, 2022, FREQUENCY HAD
CASH,
CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $83.1 MILLION OR
$68.9 MILLION NET OF DEBT
* BELIEVES RESTRUCTURING ACTIVITIES WILL GENERATE SUFFICIENT
COST
SAVINGS TO EXTEND ITS RUNWAY INTO 2025
* BELIEVES THAT RESTRUCTURING ACTIVITIES WILL ENABLE IT TO
COMPLETE A FIRST CLINICAL TRIAL OF ITS MS PROGRAM IN 2H 2024
* QTRLY LOSS PER SHARE $0.49
* Q4 EARNINGS PER SHARE VIEW $-0.63 -- REFINITIV IBES DATA
* FREQUENCY THERAPEUTICS - UNDERTAKEN ACTIONS TO REDUCE
EXPENSES &
HEADCOUNT AS PART OF OVERALL RESTRUCTURING, DOWNSIZING PERSONNEL
BY ABOUT 55%
* RESTRUCTURING CUTS WILL BE COMPLETED BY END OF APRIL 2023
Source text for Eikon: ID:nBw8L03tta
((Reuters.Briefs@thomsonreuters.com;))